We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Clarivate Plc (CLVT) Ord NPV

Sell:$5.14 Buy:$5.15 Change: $0.075 (1.47%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$5.14
Buy:$5.15
Change: $0.075 (1.47%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$5.14
Buy:$5.15
Change: $0.075 (1.47%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.

Contact details

Address:
70 St. Mary Axe
LONDON
EC3A 8BE
United Kingdom
Telephone:
+44 (20) 74334000
Website:
https://clarivate.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CLVT
ISIN:
JE00BJJN4441
Market cap:
$3.62 billion
Shares in issue:
710.40 million
Sector:
Research & Consulting Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Matitiahu Tov
    Chief Executive Officer, Director
  • Jonathan Collins
    Chief Financial Officer, Executive Vice President
  • Henry Levy
    President - Life Sciences & Health care
  • Gordon Samson
    President - Intellectual Property
  • Bar Veinstein
    President - Academia & Government
  • Julie Wilson
    Chief People Officer
  • Melanie Margolin
    Chief Administrative and Legal Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.